November 26, 2013
Pfizer Japan announced on November 22 that its anticancer agent Farmorubicin for Injection 10 mg/50 mg (epirubicin) obtained approval on the same day for a new additional dosage for the use of transcatheter arterial chemoembolization (TACE) for the treatment of...read more